Swiss National Bank cut its position in shares of XenoPort, Inc. (NASDAQ:XNPT) by 5.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 116,300 shares of the biopharmaceutical company’s stock after selling 6,200 shares during the period. Swiss National Bank’s holdings in XenoPort were worth $819,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in the stock. DUPONT CAPITAL MANAGEMENT Corp acquired a new position in shares of XenoPort during the second quarter worth $510,000. Longfellow Investment Management Co. LLC acquired a new position in shares of XenoPort during the second quarter worth $4,622,000. Kassirer Asset Management Corp acquired a new position in shares of XenoPort during the second quarter worth $2,511,000. Havens Advisors LLC acquired a new position in shares of XenoPort during the second quarter worth $880,000. Finally, Deerfield Management Co. increased its position in shares of XenoPort by 84.1% in the first quarter. Deerfield Management Co. now owns 11,572,125 shares of the biopharmaceutical company’s stock worth $52,190,000 after buying an additional 5,284,751 shares during the period.
XenoPort, Inc. (NASDAQ:XNPT) remained flat at $7.07 during trading on Friday. XenoPort, Inc. has a 52 week low of $3.35 and a 52 week high of $7.86. The stock’s 50 day moving average price is $6.71 and its 200 day moving average price is $5.20.
Separately, Zacks Investment Research downgraded XenoPort from a “hold” rating to a “sell” rating in a research report on Wednesday, July 6th.
XenoPort, Inc is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company’s segment is the development and commercialization of product candidates for the treatment of neurological and other disorders.
Want to see what other hedge funds are holding XNPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for XenoPort, Inc. (NASDAQ:XNPT).
Receive News & Ratings for XenoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XenoPort Inc. and related companies with MarketBeat.com's FREE daily email newsletter.